Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this study is to assess a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of cardiac amyloidosis (CA).

Clinical Trial Description

This pragmatic trial will be the first study to prospectively evaluate the use of the AI ECG dashboard along with an augmented report in everyday practice. The findings will also guide future implementation strategies and inform the translation of many of the current and future AI algorithms into the clinical setting. The participants are the providers. Basic demographic information about the providers will be collected as well as their reactions to the trial based educational guidance supplied to them. Patient health information will be collected on their patients using a HIPPA waiver. There will be no patient contact. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05557162
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	June 19, 2023
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04459169` - Cardiac Amyloidosis : Diagnostic Using Red Flag Signals
Recruiting	`NCT03029026` - The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
Recruiting	`NCT06034405` - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Recruiting	`NCT04915235` - Prevalence and Prognosis of Cardiac Amiloidosis in Turkey
Recruiting	`NCT02966522` - Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis	Phase 2
Terminated	`NCT03333551` - Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy	Phase 4
Recruiting	`NCT04105634` - Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT	Early Phase 1
Recruiting	`NCT05139797` - Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Not yet recruiting	`NCT05593679` - A Multi-center Cardiac PYP Scan Registry in Taiwan.
Not yet recruiting	`NCT04146415` - Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera	N/A
Not yet recruiting	`NCT06427304` - Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Recruiting	`NCT06469372` - Cardiac Amyloidosis Discovery Trial	N/A
Recruiting	`NCT04856267` - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Completed	`NCT03119558` - PET/MRI Evaluation of Cardiac Amyloid	Early Phase 1
Recruiting	`NCT02798705` - Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Not yet recruiting	`NCT04387344` - Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis
Recruiting	`NCT06129656` - Cardiac Amyloidosis Registry of University Hospital Leipzig
Terminated	`NCT01683825` - Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography	Phase 4
Withdrawn	`NCT04363294` - Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot	N/A
Not yet recruiting	`NCT04661800` - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis	N/A